Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

AGM Statement

28 Apr 2005 07:00

Torex Retail PLC28 April 2005 Torex Retail Plc AGM Statement Torex Retail Plc ("Torex Retail" or "the Group"), the UK's market leader inretail IT solutions, will today hold its inaugural Annual General Meeting. RobLoosemore, Chairman, will comment on current trading as follows: "Torex Retail performed strongly in 2004 and the momentum developed during lastyear has been carried forward into 2005. We are pleased to report that tradingto date is in line with our expectations and, with buoyant market conditions anda high level of revenue visibility, the Board remain confident of both our fullyear forecasts and the future growth prospects for the Group. In addition, we are delighted with the progress made by the Alphameric RetailDivision (ARD), which was acquired in November 2004, and which continues totrade in line with our expectations. This reflects new business wins (AnnTaylor and Littlewoods) for our Smartdecision merchandise planning product,coupled with decisive action taken to reduce the cost base. The division is nowfully integrated into the Torex Retail business." Other highlights include: • First installations of Lucas into the UK: Following the successful launch in the UK of Lucas, our market leading Java EPOS solution, installations have already been completed with Esprit, Deichmann shoe stores and a major regional department store. Further announcements are expected shortly. • Cross selling of Lucas is ahead of schedule. The very strong demand for Lucas from the former ARD customer base has resulted in a number of early contract wins, including JD Sports with installations into their 68 UK stores planned for the next quarter. In addition, Lucas has already been installed in Reiss' flagship New York store and Nora O'Connell stores in Ireland. Chris Moore, Chief Executive, comments: "I am delighted with the start we have made to the year. Most encouraging hasbeen the new contract wins for Lucas, in particular, the deal with JD Sports inthe face of stiff competition. This win, together with the UK Lucas sales, willprovide valuable reference sites from which to leverage Lucas further into theUK market. The outlook for the full year remains very positive." It is expected that the Group's interim results for the six months ending 30June, 2005 will be announced in mid September 2005. Enquiries: Torex Retail 0870 050 9900 Rob Loosemoore, Chairman / Richard Thompson, FD Citigate Dewe Rogerson 020 7638 9571 Ginny Pulbrook / Sebastian Hoyle / Lucie Holloway This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Nov 20227:00 amRNSDistribution agreement - OrthoPure® XT in Germany
14th Nov 20226:05 pmRNSHolding(s) in Company
7th Nov 20222:35 pmRNSHolding(s) in Company
29th Sep 202210:13 amRNSDirector/PDMR Shareholding
27th Sep 20227:15 amEQSHardman & Co Research on Tissue Regenix (TRX): Operating leverage
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20223:31 pmRNSHolding(s) in Company
18th Aug 20225:36 pmRNSHolding(s) in Company
18th Aug 20222:10 pmRNSHolding(s) in Company
11th Aug 20224:30 pmEQSHardman & Co Research: Q&A on Tissue Regenix Group plc: Significantly undervalued which should correct
11th Aug 202212:46 pmRNSHolding(s) in Company
11th Aug 202212:17 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSConfirmation of Interim Results
5th Aug 20223:19 pmRNSHolding(s) in Company
1st Aug 20223:14 pmRNSHolding(s) in Company
19th Jul 20222:30 pmEQSHardman & Co Research : Tissue Regenix (TRX): Strong 1H’22 sales suggest upside potential
19th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
18th Jul 20222:42 pmRNSHolding(s) in Company
18th Jul 20221:33 pmRNSHolding(s) in Company
15th Jul 20225:29 pmRNSHolding(s) in Company
27th Jun 20226:04 pmRNSHolding(s) in Company
27th Jun 202212:58 pmRNSHolding(s) in Company
16th Jun 20221:27 pmRNSExercise of Options and Total Voting Rights
28th Apr 20227:00 amRNSOrthoPure®XT clinical results presentation
26th Apr 20224:19 pmRNSResult of AGM
20th Apr 20224:26 pmRNSDirector/PDMR Shareholding
19th Apr 20227:15 amEQSHardman & Co Research: Tissue Regenix (TRX) On pathway to sustainability
8th Apr 20227:00 amRNSGrant of share options
6th Apr 20222:59 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSFinal year results for the year ended 31 Dec 2021
9th Mar 20227:00 amRNSDistribution agreement for OrthoPure® XT
2nd Mar 20227:00 amRNSNotice of Results
10th Feb 20223:45 pmRNSAdditional Director Disclosures
27th Jan 20227:00 amRNSFull Year Trading update
23rd Dec 20217:00 amRNSDirector/PDMR Shareholding
21st Dec 20212:06 pmRNSSecond Price Monitoring Extn
21st Dec 20212:01 pmRNSPrice Monitoring Extension
19th Oct 20211:15 pmEQSHardman & Co Research: Tissue Regenix (TRX): Faster-than-anticipated recovery
8th Oct 20217:00 amRNSHolding(s) in Company
5th Oct 20214:44 pmRNSHolding(s) in Company
28th Sep 20217:00 amRNSHolding(s) in Company
24th Sep 20212:05 pmRNSDirector/PDMR Shareholding
9th Sep 20214:35 pmRNSDirector/PDMR Shareholding
8th Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSLaunch of DermaPure® Meshed and VNEWTM
1st Sep 20217:00 amRNSNotice of Results
16th Aug 20217:00 amRNSHolding(s) in Company
14th Jul 20213:15 pmEQSHardman & Co Research: Q&A with Dr Martin Hall on Tissue Regenix Group Plc: New capacity now on stream
30th Jun 202111:56 amEQSHardman & Co Research: Tissue Regenix (TRX): Poised for growth
29th Jun 20211:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.